Continuing PC vaccine in Kenya at full price cost-effective and could save thousands of lives

(London School of Hygiene & Tropical Medicine) Continuing the pneumococcal conjugate vaccine (PCV) in Kenya after the country transitions away from Gavi, the Vaccine Alliance, support is highly cost-effective and estimated to save thousands of children's lives, according to new research published in The Lancet Global Health.

from EurekAlert! - Social and Behavioral Science http://bit.ly/2UF5LZg